Table 6.
Myocarditis and pericarditis events reported to VAERS following Moderna COVID-19 vaccine (Spikevax), by dose Datalock point 14 March 2022
| Age group | Myocarditis | Pericarditis | ||||||||||||||
| Male | Female | Sex not specified | Total | Male | Female | Sex not specified | Total | |||||||||
| n | % | n | % | n | % | N | % | n | % | n | % | N | % | N | % | |
| Dose 1 | ||||||||||||||||
| <6 months | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 3–5 Years | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 6–17 Years | 1 | 0.56 | 0 | 0.00 | 0 | 0.00 | 1 | 0.35 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 18–29 Years | 74 | 41.11 | 18 | 18.00 | 0 | 0.00 | 92 | 32.17 | 33 | 32.35 | 23 | 20.00 | 0 | 0.00 | 56 | 25.23 |
| 30–39 years | 42 | 23.33 | 18 | 18.00 | 0 | 0.00 | 60 | 20.98 | 15 | 14.71 | 17 | 14.78 | 0 | 0.00 | 32 | 14.41 |
| 40–49 years | 16 | 8.89 | 21 | 21.00 | 0 | 0.00 | 37 | 12.94 | 21 | 20.59 | 20 | 17.39 | 0 | 0.00 | 41 | 18.47 |
| 50–59 years | 15 | 8.33 | 16 | 16.00 | 1 | 16.67 | 32 | 11.19 | 12 | 11.76 | 19 | 16.52 | 0 | 0.00 | 31 | 13.96 |
| 60–64 years | 3 | 1.67 | 15 | 15.00 | 0 | 0.00 | 18 | 6.29 | 7 | 6.86 | 12 | 10.43 | 0 | 0.00 | 19 | 8.56 |
| 65–79 Years | 10 | 5.56 | 11 | 11.00 | 0 | 0.00 | 21 | 7.34 | 11 | 10.78 | 16 | 13.91 | 2 | 40.00 | 29 | 13.06 |
| 80+ Years | 2 | 1.11 | 1 | 1.00 | 0 | 0.00 | 3 | 1.05 | 0 | 0.00 | 5 | 4.35 | 0 | 0.00 | 5 | 2.25 |
| Not specified | 17 | 9.44 | 0 | 0.00 | 5 | 83.33 | 22 | 7.69 | 3 | 2.94 | 3 | 2.61 | 3 | 60.00 | 9 | 4.05 |
| Total | 180 | 100.00 | 100 | 100.00 | 6 | 100.00 | 286 | 100.00 | 102 | 100.00 | 115 | 100.00 | 5 | 100.00 | 222 | 100.00 |
| Dose 2 | ||||||||||||||||
| <6 months | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 3–5 Years | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 6–17 Years | 2 | 0.72 | 0 | 0.00 | 0 | 0.00 | 2 | 0.52 | 1 | 0.55 | 0 | 0.00 | 0 | 0.00 | 1 | 0.33 |
| 18–29 Years | 152 | 54.48 | 29 | 29.00 | 1 | 20.00 | 182 | 47.40 | 63 | 34.81 | 24 | 19.67 | 0 | 0.00 | 87 | 28.52 |
| 30–39 years | 57 | 20.43 | 15 | 15.00 | 0 | 0.00 | 72 | 18.75 | 30 | 16.57 | 11 | 9.02 | 0 | 0.00 | 41 | 13.44 |
| 40–49 years | 24 | 8.60 | 24 | 24.00 | 0 | 0.00 | 48 | 12.50 | 20 | 11.05 | 21 | 17.21 | 0 | 0.00 | 41 | 13.44 |
| 50–59 years | 20 | 7.17 | 13 | 13.00 | 0 | 0.00 | 33 | 8.59 | 25 | 13.81 | 24 | 19.67 | 0 | 0.00 | 49 | 16.07 |
| 60–64 years | 6 | 2.15 | 5 | 5.00 | 0 | 0.00 | 11 | 2.86 | 10 | 5.52 | 12 | 9.84 | 0 | 0.00 | 22 | 7.21 |
| 65–79 Years | 13 | 4.66 | 12 | 12.00 | 0 | 0.00 | 25 | 6.51 | 26 | 14.36 | 26 | 21.31 | 0 | 0.00 | 52 | 17.05 |
| 80+ Years | 1 | 0.36 | 1 | 1.00 | 0 | 0.00 | 2 | 0.52 | 4 | 2.21 | 4 | 3.28 | 0 | 0.00 | 8 | 2.62 |
| Not specified | 4 | 1.43 | 1 | 1.00 | 4 | 80.00 | 9 | 2.34 | 2 | 1.10 | 0 | 0.00 | 2 | 100.00 | 4 | 1.31 |
| Total | 279 | 100.00 | 100 | 100.00 | 5 | 100.00 | 384 | 100.00 | 181 | 100.00 | 122 | 100.00 | 2 | 100.00 | 305 | 100.00 |
| Dose 3 | ||||||||||||||||
| <6 months | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 3–5 Years | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 6–17 Years | 1 | 1.96 | 0 | 0.00 | 0 | 0.00 | 1 | 1.16 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 18–29 Years | 29 | 56.86 | 8 | 22.86 | 0 | 0.00 | 37 | 43.02 | 10 | 29.41 | 6 | 16.22 | 0 | 0.00 | 16 | 22.54 |
| 30–39 years | 9 | 17.65 | 10 | 28.57 | 0 | 0.00 | 19 | 22.09 | 4 | 11.76 | 7 | 18.92 | 0 | 0.00 | 11 | 15.49 |
| 40–49 years | 6 | 11.76 | 4 | 11.43 | 0 | 0.00 | 10 | 11.63 | 5 | 14.71 | 8 | 21.62 | 0 | 0.00 | 13 | 18.31 |
| 50–59 years | 2 | 3.92 | 4 | 11.43 | 0 | 0.00 | 6 | 6.98 | 7 | 20.59 | 5 | 13.51 | 0 | 0.00 | 12 | 16.90 |
| 60–64 years | 1 | 1.96 | 2 | 5.71 | 0 | 0.00 | 3 | 3.49 | 1 | 2.94 | 3 | 8.11 | 0 | 0.00 | 4 | 5.63 |
| 65–79 Years | 3 | 5.88 | 6 | 17.14 | 0 | 0.00 | 9 | 10.47 | 6 | 17.65 | 6 | 16.22 | 0 | 0.00 | 12 | 16.90 |
| 80+Years | 0 | 0.00 | 1 | 2.86 | 0 | 0.00 | 1 | 1.16 | 1 | 2.94 | 2 | 5.41 | 0 | 0.00 | 3 | 4.23 |
| Not specified | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Total | 51 | 100.00 | 35 | 100.00 | 0 | 0.00 | 86 | 100.00 | 34 | 100.00 | 37 | 100.00 | 0 | 0.00 | 71 | 100.00 |
| Dose 4+ | ||||||||||||||||
| 40–49 Years | 0 | 0.00 | 1 | 100.00 | 0 | 0.00 | 1 | 100.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Total | 0 | 0.00 | 1 | 100.00 | 0 | 0.00 | 1 | 100.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Unknown dose | ||||||||||||||||
| <6 months | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 3–5 Years | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 6–17 Years | 1 | 0.74 | 1 | 3.03 | 2 | 25.00 | 4 | 2.27 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| 18–29 Years | 62 | 45.93 | 9 | 27.27 | 0 | 0.00 | 71 | 40.34 | 24 | 32.88 | 9 | 30.00 | 0 | 0.00 | 33 | 30.28 |
| 30–39 years | 27 | 20.00 | 8 | 24.24 | 0 | 0.00 | 35 | 19.89 | 10 | 13.70 | 3 | 10.00 | 1 | 16.67 | 14 | 12.84 |
| 40–49 years | 16 | 11.85 | 1 | 3.03 | 0 | 0.00 | 17 | 9.66 | 11 | 15.07 | 5 | 16.67 | 0 | 0.00 | 16 | 14.68 |
| 50–59 years | 4 | 2.96 | 4 | 12.12 | 0 | 0.00 | 8 | 4.55 | 8 | 10.96 | 4 | 13.33 | 0 | 0.00 | 12 | 11.01 |
| 60–64 years | 5 | 3.70 | 2 | 6.06 | 0 | 0.00 | 7 | 3.98 | 6 | 8.22 | 4 | 13.33 | 1 | 16.67 | 11 | 10.09 |
| 65–79 Years | 3 | 2.22 | 6 | 18.18 | 0 | 0.00 | 9 | 5.11 | 11 | 15.07 | 5 | 16.67 | 0 | 0.00 | 16 | 14.68 |
| 80+ Years | 2 | 1.48 | 1 | 3.03 | 0 | 0.00 | 3 | 1.70 | 1 | 1.37 | 0 | 0.00 | 0 | 0.00 | 1 | 0.92 |
| Not specified | 15 | 11.11 | 1 | 3.03 | 6 | 75.00 | 22 | 12.50 | 2 | 2.74 | 0 | 0.00 | 4 | 66.67 | 6 | 5.50 |
| Total | 135 | 100.00 | 33 | 100.00 | 8 | 100.00 | 176 | 100.00 | 73 | 100.00 | 30 | 100.00 | 6 | 100.00 | 109 | 100.00 |
| Grand Total | 645 | 269 | 19 | 933 | 390 | 304 | 13 | 707 | ||||||||
Percentages per age group are presented.